1. Home
  2. UG vs KTTA Comparison

UG vs KTTA Comparison

Compare UG & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo United-Guardian Inc.

UG

United-Guardian Inc.

HOLD

Current Price

$6.62

Market Cap

27.7M

ML Signal

HOLD

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

HOLD

Current Price

$0.74

Market Cap

26.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UG
KTTA
Founded
1942
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Package Goods/Cosmetics
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.7M
26.7M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
UG
KTTA
Price
$6.62
$0.74
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
14.9K
144.4K
Earning Date
03-20-2026
03-23-2026
Dividend Yield
7.47%
N/A
EPS Growth
N/A
N/A
EPS
0.43
N/A
Revenue
$10,060,322.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$15.68
N/A
Revenue Growth
N/A
N/A
52 Week Low
$5.58
$0.28
52 Week High
$11.08
$3.79

Technical Indicators

Market Signals
Indicator
UG
KTTA
Relative Strength Index (RSI) 49.31 32.21
Support Level $6.25 $0.71
Resistance Level $7.41 $0.87
Average True Range (ATR) 0.31 0.04
MACD -0.04 -0.01
Stochastic Oscillator 32.58 19.63

Price Performance

Historical Comparison
UG
KTTA

About UG United-Guardian Inc.

United-Guardian Inc manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and specialty industrial products. Its product portfolio includes Klensoft, Deselex, Renacidin, Lubrajel Fluid. The company's pharmaceutical products are sold to and distributed by full-line drug wholesalers throughout the United States. Its medical and specialty industrial products are sold directly by the company to the end-users of those products or, in some cases, to contract manufacturers used by some of those end users. It operates in one business segment and its current product lines are separated into four distinct product categories that are cosmetic ingredients, pharmaceuticals, medical lubricants and sexual wellness. It derives key revenue from the sales made in the U.S.

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

Share on Social Networks: